Insider filing · BPMC
Jeffrey W. Albers sold $512K of Blueprint Medicines (BPMC)
Executed Mar 5 2025, disclosed Mar 17 2025, 12 days later, against a two-business-day limit.
Value, as filed
$512K
5,766 sh × $88.80
Executed
Mar 5 2025
the trade date, as filed
Disclosed
Mar 17 2025
12 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JA
Jeffrey W. Albers
Director
profile →
Jeffrey W. Albers (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BPMC. The largest single filing was $2.4M of SYRE (23,000 sh across 3 lots, as filed), executed Aug 7.
The name
BPMC
BPMC
BPMC · 35 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Jeffrey W. Albers in BPMC
BPMCSALE
Blueprint Medicines Corp
$439K4,350 sh × $101.02
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $658K
7,500 sh across 2 lots
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $1.6M
14,961 sh across 2 lots
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $511K
5,000 sh × $102.28
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $1.3M
15,000 sh across 4 lots
Exec Dec 19 2024
Filed Dec 20 2024 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $510K
5,000 sh × $102.00
Exec Nov 7 2024
Filed Nov 12 2024 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp $1.7M
19,702 sh across 2 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET